Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
n-Lorem is a nonprofit that uses antisense technology to develop experimental antisense oligonucleotide medicines for nano-rare diseases. These ASO medicines are provided to patients at no cost for life, and the organization runs pathways to treatment, active gene programs, and patient- and physician-readiness resources to connect patients with therapies. They engage the community with events like the Nano-rare Patient Colloquium and support fundraising and partnerships to accelerate access to experimental treatments.
Parse Score
Sources
nlorem.org shapes more of what AI says about n-Lorem Foundation than any other source, at 67% of its citations.
oligotherapeutics.org